In the Pipeline: Restoring Dystrophin - PTC Therapeutics (Ataluren)
In the Pipeline: Dystrophin Restoration (PPMD's 2021 Virtual Annual Conference)
In the Pipeline: Restoring Dystrophin - Sarepta Therapeutics (RNA Targeted Therapies)
In the Pipeline: Restoring Dystrophin - Day 2 - PPMD Annual 2020
In the Pipeline: Restoring Dystrophin - Daiichi-Sankyo
In the Pipeline: Restoring Dystrophin - NS Pharma
PPMD 2018 Conference - Restoring or Replacing Dystrophin
In the Pipeline: Reducing Inflammation - Day 1 - PPMD Annual 2020
In the Pipeline: Reducing Inflammation - Catabasis
PPMD 2025 Annual Conference: Day 2 - Dystrophin: The Missing Muscle Protein
Restoring Dystrophin via Exon Skipping Strategies -- PPMD 2022 Annual Conference
Gene Therapy Approaches to Replace or Restore Dystrophin -- PPMD 2022 Annual Conference
In the Pipeline: Gene Therapy - Sarepta Therapeutics
In the Pipeline: Reducing Inflammation - ReveraGen BioPharma
Duchenne Landscape: Where We've Come From & How We're Moving Forward -- PPMD 2022 Annual Conference
In the Pipeline: Gene Therapy - Day 3 - PPMD Annual 2020
CureDuchenne Webinar with Edgewise Therapeutics: A Novel Approach to Protect Muscle in Duchenne
In the Pipeline: Gene Therapy - Pfizer Inc.
PPMD 2020 Annual Conference - Thursday, July 23, 2020 (Full Program)
Cure Rare Disease: Demystifying dystrophin quantification
